Lentiviral vectors
OwnerLung-Ji Changinventor
Life of this patent
Estimating the term…
Abstract
The present invention contemplates novel lentiviral vectors which exhibit strong promoter activity in human and other cells. Vectors are provided which are packaged efficiently in packaging cells and cell lines to generate high titer recombinant virus stocks. The present invention further relates to HIV vaccines and compositions for gene therapy. In particular, the present invention provides attenuated replication-competent HIV vaccines and replication-defective HIV vectors.
Claims40
A packaging vector comprising a nucleotide sequence encoding Gag and Pol proteins of a reference lentivirus, said packaging vector differing from said reference lentivirus at least in that
- (a) it lacks a functional major splice donor site, or its manor splice donor site, while functional, differs in sequence from that of said reference lentivirus, and
- (b) it lacks a functional major packaging signal, which vector, after introduction into a suitable host cell, is capable of causing such cell, either through expression from said vector alone, or through co-expression from said vector and a second vector providing for expression of a compatible envelope protein, to produce packaging vector particles comprising functional Gag and Pol proteins and having a normal or a pseudotyped envelope, where said particles are free of the RNA form of said packaging vector as a result of (b) above,
- where said cell, as a result of said expression or co-expression, produces particles encapsulating the RNA form of a transducing vector possessing a compatible and functional packaging signal if said transducing vector is introduced into said cell,
- where said reference lentivirus is a human or simian immunodeficiency virus.
Dependencies are inferred from the claim text.